Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania Inc
Search grants from University of Pennsylvania Inc
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identification of F-Box Proteins in Toxoplasma
Dopamine Effects on Mesocorticolimbic Function in Parkinson Disease
Invasive breast cancer with and without DCIS: Race, risk factors and outcomes
Dorsal Gradient Formation in the Early Drosophila Embryo
Abo Antibodies - Paradigm for Human Repertoire Evolution
Recently added grants:
Accelerated and programmed mRNA decay by AU-rich binding protein AUF1 in the regulation of muscle regeneration
Mechanisms underlying tendon regeneration and attachment site pattern restoration
Follicular Helper T Cell Function in Autoimmunity
Roles of Chromatin Modification in BRCA1 Dependent DNA Repair
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025118-002
Application #
6828862
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
NIH 2002
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
Comments
Be the first to comment on this grant